{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["blood\u2013brain barrier (BBB) and blood\u2013cerebrospinal fluid barrier (BCSFB)", "brain disorders", "drug transporters", "natural compound\u2013drug interactions (NDIs)", "pharmacokinetics"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33670407", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "14"}, "DateRevised": {"Year": "2021", "Month": "04", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "11"}], "Language": ["eng"], "ELocationID": ["1809", "10.3390/ijms22041809"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "22", "Issue": "4", "PubDate": {"Year": "2021", "Month": "Feb", "Day": "11"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Impacts of Drug Interactions on Pharmacokinetics and the Brain Transporters: A Recent Review of Natural Compound-Drug Interactions in Brain Disorders.", "Abstract": {"AbstractText": ["Natural compounds such as herbal medicines and/or phyto-compounds from foods, have frequently been used to exert synergistic therapeutic effects with anti-brain disorder drugs, supplement the effects of nutrients, and boost the immune system. However, co-administration of natural compounds with the drugs can cause synergistic toxicity or impeditive drug interactions due to changes in pharmacokinetic properties (e.g., absorption, metabolism, and excretion) and various drug transporters, particularly brain transporters. In this review, natural compound-drug interactions (NDIs), which can occur during the treatment of brain disorders, are emphasized from the perspective of pharmacokinetics and cellular transport. In addition, the challenges emanating from NDIs and recent approaches are discussed."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Mokpo National University, Muan-gun, Jeonnam 58554, Korea."}], "LastName": "Khadka", "ForeName": "Bikram", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Chungnam National University, Daejeon 34134, Korea."}], "LastName": "Lee", "ForeName": "Jae-Young", "Initials": "JY"}, {"Identifier": ["0000-0001-8006-6402"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology and Regenerative Medicine, School of Dentistry, Kyungpook National University, Daegu 41940, Korea."}], "LastName": "Park", "ForeName": "Eui Kyun", "Initials": "EK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Mokpo National University, Muan-gun, Jeonnam 58554, Korea."}, {"Identifier": [], "Affiliation": "College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Muan-gun, Jeonnam 58554, Korea."}], "LastName": "Kim", "ForeName": "Ki-Taek", "Initials": "KT"}, {"Identifier": ["0000-0002-5756-9367"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Korea."}], "LastName": "Bae", "ForeName": "Jong-Sup", "Initials": "JS"}], "GrantList": [{"GrantID": "NRF-2017R1A5A2015391", "Agency": "National Research Foundation of Korea", "Country": ""}, {"GrantID": "NRF-2018M3A7B4071204", "Agency": "National Research Foundation of Korea", "Country": ""}, {"GrantID": "NRF-2019R1G1A1099756", "Agency": "National Research Foundation of Korea", "Country": ""}, {"GrantID": "NRF-2020R1A2C1004131", "Agency": "National Research Foundation of Korea", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Membrane Transport Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Biological Transport"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Blood-Brain Barrier"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Brain Diseases"}, {"QualifierName": [], "DescriptorName": "Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Membrane Transport Proteins"}, {"QualifierName": ["agonists", "antagonists & inhibitors", "pharmacokinetics", "therapeutic use"], "DescriptorName": "Phytochemicals"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Kim K.T., Lee H.S., Lee J.J., Park E.K., Lee B.S., Lee J.Y., Bae J.S. Nanodelivery systems for overcoming limited transportation of therapeutic molecules through the blood-brain barrier. Future Med. Chem. 2018;10:2659\u20132674. doi: 10.4155/fmc-2018-0208.", "ArticleIdList": ["10.4155/fmc-2018-0208", "30499740"]}, {"Citation": "Makkar R., Behl T., Bungau S., Zengin G., Mehta V., Kumar A., Uddin M.S., Ashraf G.M., Abdel-Daim M.M., Arora S., et al. Nutraceuticals in neurological disorders. Int. J. Mol. Sci. 2020;21:4424. doi: 10.3390/ijms21124424.", "ArticleIdList": ["10.3390/ijms21124424", "PMC7352709", "32580329"]}, {"Citation": "Uddin M.S., Hossain M.F., Mamun A.A., Shah M.A., Hasana S., Bulbul I.J., Sarwar M.S., Mansouri R.A., Ashraf G.M., Rauf A., et al. Exploring the multimodal role of phytochemicals in the modulation of cellular signaling pathways to combat age-related neurodegeneration. Sci. Total Environ. 2020;725:138313. doi: 10.1016/j.scitotenv.2020.138313.", "ArticleIdList": ["10.1016/j.scitotenv.2020.138313", "32464743"]}, {"Citation": "Kibathi L.W., Bae S.H., Penzak S.R., Kumar P. Potential influence of centrally acting herbal drugs on transporters at the blood-cerebrospinal fluid barrier and blood-brain barrier. Eur. J. Drug Metab. Pharmacokinet. 2018;43:619\u2013635. doi: 10.1007/s13318-018-0486-6.", "ArticleIdList": ["10.1007/s13318-018-0486-6", "29858835"]}, {"Citation": "Khadka B., Lee J.Y., Park D.H., Kim K.T., Bae J.S. The role of natural compounds and their nanocarriers in the treatment of CNS inflammation. Biomolecules. 2020;10:1401. doi: 10.3390/biom10101401.", "ArticleIdList": ["10.3390/biom10101401", "PMC7601486", "33019651"]}, {"Citation": "Borse S.P., Singh D.P., Nivsarkar M. Understanding the relevance of herb-drug interaction studies with special focus on interplays: A prerequisite for integrative medicine. Porto Biomed. J. 2019;4:e15. doi: 10.1016/j.pbj.0000000000000015.", "ArticleIdList": ["10.1016/j.pbj.0000000000000015", "PMC6726296", "31595257"]}, {"Citation": "Roberts A.G., Gibbs M.E. Mechanisms and the clinician relevance of complex drug-drug interactions. Clin. Pharmacol. 2018;10:123\u2013134.", "ArticleIdList": ["PMC6166769", "30310332"]}, {"Citation": "Qosa H., Miller D.S., Pasinelli P., Trotti D. Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders. Brain Res. 2015;1628:298\u2013316. doi: 10.1016/j.brainres.2015.07.005.", "ArticleIdList": ["10.1016/j.brainres.2015.07.005", "PMC4681613", "26187753"]}, {"Citation": "Vengoji R., Macha M.A., Batra S.K., Shonka N.A. Natural products: A hope for glioblastoma patients. Oncotarget. 2018;9:22194\u201322219. doi: 10.18632/oncotarget.25175.", "ArticleIdList": ["10.18632/oncotarget.25175", "PMC5955138", "29774132"]}, {"Citation": "K\u00f6nig J., M\u00fcller F., Fromm M.F. Transporters and drug-drug interactions: Important determinants of drug disposition and effects. Pharmacol. Rev. 2013;65:944\u2013966. doi: 10.1124/pr.113.007518.", "ArticleIdList": ["10.1124/pr.113.007518", "23686349"]}, {"Citation": "Redzic Z. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: Similarities and differences. Fluids Barriers CNS. 2011;8:3. doi: 10.1186/2045-8118-8-3.", "ArticleIdList": ["10.1186/2045-8118-8-3", "PMC3045361", "21349151"]}, {"Citation": "Tietz S., Engelhardt B. Brain barriers: Crosstalk between complex tight junctions and adherens junctions. J. Cell Biol. 2015;209:493\u2013506. doi: 10.1083/jcb.201412147.", "ArticleIdList": ["10.1083/jcb.201412147", "PMC4442813", "26008742"]}, {"Citation": "Dias M.C., Mapunda J.A., Vladymyrov M., Engelhardt B. Structure and junctional complexes of endothelial, epithelial and glial brain barriers. Int. J. Mol. Sci. 2019;20:5372. doi: 10.3390/ijms20215372.", "ArticleIdList": ["10.3390/ijms20215372", "PMC6862204", "31671721"]}, {"Citation": "Parashar P., Diwaker N., Kanoujia J., Singh M., Yadav A., Singh I., Saraf S.A. In situ gel of lamotrigine for augmented brain delivery: Development, characterization and pharmacokinetic evaluation. J. Pharm. Investig. 2020;50:95\u2013105. doi: 10.1007/s40005-019-00436-0.", "ArticleIdList": ["10.1007/s40005-019-00436-0"]}, {"Citation": "Ag\u00fandez J.A., Jim\u00e9nez-Jim\u00e9nez F.J., Alonso-Navarro H., Garc\u00eda-Mart\u00edn E. Drug and xenobiotic biotransformation in the blood-brain barrier: A neglected issue. Front. Cell. Neurosci. 2014;8:335.", "ArticleIdList": ["PMC4201098", "25368552"]}, {"Citation": "Eyal S., Hsiao P., Unadkat J.D. Drug interactions at the blood-brain barrier: Fact or fantasy? Pharmacol. Ther. 2009;123:80\u2013104. doi: 10.1016/j.pharmthera.2009.03.017.", "ArticleIdList": ["10.1016/j.pharmthera.2009.03.017", "PMC2751796", "19393264"]}, {"Citation": "Chan G.N., Hoque T., Bendayan R. Role of nuclear receptors in the regulation of drug transporters in the brain. Trends Pharmacol. Sci. 2013;34:361\u2013372. doi: 10.1016/j.tips.2013.05.004.", "ArticleIdList": ["10.1016/j.tips.2013.05.004", "23769624"]}, {"Citation": "Han D.G., Cho S.S., Kwak J.H., Yoon I.S. Medicinal plants and phytochemicals for diabetes mellitus: Pharmacokinetic characteristics and herb-drug interactions. J. Pharm. Investig. 2019;49:603\u2013612. doi: 10.1007/s40005-019-00440-4.", "ArticleIdList": ["10.1007/s40005-019-00440-4"]}, {"Citation": "M\u00fcller F., Fromm M.F. Transporter-mediated drug-drug interactions. Pharmacogenomics. 2011;12:1017\u20131037. doi: 10.2217/pgs.11.44.", "ArticleIdList": ["10.2217/pgs.11.44", "21787191"]}, {"Citation": "International Transporter Consortium. Giacomini K.M., Huang S.M., Tweedie D.J., Benet L.Z., Brouwer K.L., Chu X., Dahlin A., Evers R., Fischer V., et al. Membrane transporters in drug development. Nat. Rev. Drug Discov. 2010;9:215\u2013236.", "ArticleIdList": ["PMC3326076", "20190787"]}, {"Citation": "Jeong S.H., Jang J.H., Cho H.Y., Oh I.J., Lee Y.B. A sensitive UPLC-ESI-MS/MS method for the quantification of cinnamic acid in vivo and in vitro: Application to pharmacokinetic and protein binding study in human plasma. J. Pharm. Investig. 2020;50:159\u2013172. doi: 10.1007/s40005-019-00444-0.", "ArticleIdList": ["10.1007/s40005-019-00444-0"]}, {"Citation": "Singh A., Zhao K. Herb-drug interactions of commonly used Chinese medicinal herbs. Int. Rev. Neurobiol. 2017;135:197\u2013232.", "ArticleIdList": ["28807159"]}, {"Citation": "Sewradj S., Braver M., Vermeulen N., Commandeur J., Richert L., Vos J. Inter-donor variability of phase I/phase II metabolism of three reference drugs in cryopreserved primary human hepatocytes in suspension and monolayer. Toxicol. In Vitro. 2016;33:71\u201379. doi: 10.1016/j.tiv.2016.02.013.", "ArticleIdList": ["10.1016/j.tiv.2016.02.013", "26921663"]}, {"Citation": "Pandit S., Kanjilal S., Awasthi A., Chaudhary A., Banerjee D., Bhatt B.N., Narwaria A., Singh R., Dutta K., Jaggi M., et al. Evaluation of herb-drug interaction of a polyherbal Ayurvedic formulation through high throughput cytochrome P450 enzyme inhibition assay. J. Ethnopharmacol. 2017;197:165\u2013172.", "ArticleIdList": ["27457692"]}, {"Citation": "Thelen K., Dressman J.B. Cytochrome P450-mediated metabolism in the human gut wall. J. Pharm. Pharmacol. 2009;61:541\u2013558. doi: 10.1211/jpp.61.05.0002.", "ArticleIdList": ["10.1211/jpp.61.05.0002", "19405992"]}, {"Citation": "Xie F., Ding X., Zhang Q.Y. An update on the role of intestinal cytochrome P450 enzymes in drug disposition. Acta Pharm. Sin. B. 2016;6:374\u2013383. doi: 10.1016/j.apsb.2016.07.012.", "ArticleIdList": ["10.1016/j.apsb.2016.07.012", "PMC5045550", "27709006"]}, {"Citation": "Ghosh C., Puvenna V., Gonzalez-Martinez J., Janigro D., Marchi N. Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: A synergistic role in neurological diseases. Curr. Drug Metab. 2011;12:742\u2013749. doi: 10.2174/138920011798357051.", "ArticleIdList": ["10.2174/138920011798357051", "PMC4874186", "21568937"]}, {"Citation": "Naumann S., Haller D., Eisner P., Schweiggert-Weisz U. Mechanisms of interactions between bile acids and plant compounds-A review. Int. J. Mol. Sci. 2020;21:6495.", "ArticleIdList": ["PMC7555273", "32899482"]}, {"Citation": "Wu X., Ma J., Ye Y., Lin G. Transporter modulation by Chinese herbal medicines and its mediated pharmacokinetic herb-drug interactions. J. Chromatogr. B. 2016;1026:236\u2013253. doi: 10.1016/j.jchromb.2015.11.024.", "ArticleIdList": ["10.1016/j.jchromb.2015.11.024", "26675080"]}, {"Citation": "Yin J., Wang J. Renal drug transporters and their significance in drug-drug interactions. Acta Pharm. Sin. B. 2016;6:363\u2013373. doi: 10.1016/j.apsb.2016.07.013.", "ArticleIdList": ["10.1016/j.apsb.2016.07.013", "PMC5045553", "27709005"]}, {"Citation": "Ivanyuk A., Livio F., Biollaz J., Buclin T. Renal drug transporters and drug interactions. Clin. Pharmacokinet. 2017;56:825\u2013892. doi: 10.1007/s40262-017-0506-8.", "ArticleIdList": ["10.1007/s40262-017-0506-8", "28210973"]}, {"Citation": "Niu J., Straubinger R.M., Mager D.E. Pharmacodynamic drug-drug interactions. Clin. Pharmacol. Ther. 2019;105:1395\u20131406. doi: 10.1002/cpt.1434.", "ArticleIdList": ["10.1002/cpt.1434", "PMC6529235", "30912119"]}, {"Citation": "Efferth T., Koch E. Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr. Drug Targets. 2011;12:122\u2013132. doi: 10.2174/138945011793591626.", "ArticleIdList": ["10.2174/138945011793591626", "20735354"]}, {"Citation": "Caesar L.K., Cech N.B. Synergy and antagonism in natural product extracts: When 1+1 dose not equal 2. Nat. Prod. Rep. 2019;36:869\u2013888. doi: 10.1039/C9NP00011A.", "ArticleIdList": ["10.1039/C9NP00011A", "PMC6820002", "31187844"]}, {"Citation": "Vakil V., Trappe W. Drug combinations: Mathematical modeling and networking methods. Pharmaceutics. 2019;11:208. doi: 10.3390/pharmaceutics11050208.", "ArticleIdList": ["10.3390/pharmaceutics11050208", "PMC6571786", "31052580"]}, {"Citation": "Erickson M.A., Banks W.A. Age-associated changes in the immune system and blood-brain barrier functions. Int. J. Mol. Sci. 2019;20:1632. doi: 10.3390/ijms20071632.", "ArticleIdList": ["10.3390/ijms20071632", "PMC6479894", "30986918"]}, {"Citation": "Chen R.L., Kassem N.A., Redzic Z.B., Chen C.P., Segal M.B., Preston J.E. Age-related changes in choroid plexus and blood-cerebrospinal fluid barrier function in the sheep. Exp. Gerontol. 2009;44:289\u2013296. doi: 10.1016/j.exger.2008.12.004.", "ArticleIdList": ["10.1016/j.exger.2008.12.004", "19133323"]}, {"Citation": "Obermeier B., Daneman R., Ransohoff R.M. Development, maintenance and disruption of the blood-brain barrier. Nat. Med. 2013;19:1584\u20131596. doi: 10.1038/nm.3407.", "ArticleIdList": ["10.1038/nm.3407", "PMC4080800", "24309662"]}, {"Citation": "Gomez-Zepeda D., Taghi M., Scherrmann J.M., Decleves X., Menet M.C. ABC transporters at the blood-brain interfaces, their study models, and drug delivery implications in gliomas. Pharmaceutics. 2020;12:20. doi: 10.3390/pharmaceutics12010020.", "ArticleIdList": ["10.3390/pharmaceutics12010020", "PMC7022905", "31878061"]}, {"Citation": "Wang G.X., Wang D.W., Liu Y., Ma Y.H. Intractable epilepsy and the P-glycoprotein hypothesis. Int. J. Neurosci. 2016;126:385\u2013392. doi: 10.3109/00207454.2015.1038710.", "ArticleIdList": ["10.3109/00207454.2015.1038710", "26000919"]}, {"Citation": "DeMars K.M., Yang C., Hawkins K.E., McCrea A.O., Siwarski D.M., Candelario-Jalil E. Spatiotemporal changes in p-glycoprotein levels in brain and peripheral tissues following ischemic stroke in rats. J. Exp. Neurosci. 2017;11:1\u20139. doi: 10.1177/1179069517701741.", "ArticleIdList": ["10.1177/1179069517701741", "PMC5398227", "28469478"]}, {"Citation": "Erd\u00f6 F., Krajcsi P. Age-related functional and expressional changes in efflux pathways at the blood-brain barrier. Front. Aging Neurosci. 2019;11:196. doi: 10.3389/fnagi.2019.00196.", "ArticleIdList": ["10.3389/fnagi.2019.00196", "PMC6682691", "31417399"]}, {"Citation": "Qosa H., Mohamed L.A., Alqahtani S., Abuasal B.S., Hill R.A., Kaddoumi A. Transporters as drug targets in neurological diseases. Clin. Pharmacol. Ther. 2016;100:441\u2013453. doi: 10.1002/cpt.435.", "ArticleIdList": ["10.1002/cpt.435", "PMC5056151", "27447939"]}, {"Citation": "Matsuo H., Tomiyama H., Satake W., Chiba T., Onoue H., Kawamura Y., Nakayama A., Shimizu S., Sakiyama M., Funayama M., et al. ABCG2 variant has opposing effects on onset ages of Parkinson\u2019s disease and gout. Ann. Clin. Transl. Neurol. 2015;2:302\u2013306. doi: 10.1002/acn3.167.", "ArticleIdList": ["10.1002/acn3.167", "PMC4369280", "25815357"]}, {"Citation": "Ohtsuki S., Yamaguchi H., Kang Y.S., Hori S., Terasaki T. Reduction of L-type amino acid transporter 1 mRNA expression in brain capillaries in a mouse model of Parkinson\u2019s disease. Biol. Pharm. Bull. 2010;33:1250\u20131252. doi: 10.1248/bpb.33.1250.", "ArticleIdList": ["10.1248/bpb.33.1250", "20606323"]}, {"Citation": "Rombol\u00e0 L., Scuteri D., Marilisa S., Watanabe C., Morrone L.A., Bagetta G., Corasaniti M.T. Pharmacokinetic interactions between herbal medicines and drugs: Their mechanisms and clinical relevance. Life. 2020;10:106. doi: 10.3390/life10070106.", "ArticleIdList": ["10.3390/life10070106", "PMC7400069", "32635538"]}, {"Citation": "Fong S.Y., Gao Q., Zuo Z. Interaction of carbamazepine with herbs, dietary supplements, and food: A systematic review. Evid. Based Complement. Altern. Med. 2013;2013:898261. doi: 10.1155/2013/898261.", "ArticleIdList": ["10.1155/2013/898261", "PMC3760091", "24023584"]}, {"Citation": "Garg S.K., Kumar N., Bhargava V.K., Prabhakar S.K. Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clin. Pharmacol. Ther. 1998;64:286\u2013288. doi: 10.1016/S0009-9236(98)90177-1.", "ArticleIdList": ["10.1016/S0009-9236(98)90177-1", "9757152"]}, {"Citation": "Bhagat A., Bavaskar S., Tamboli J.A., Nighute A.B., Bhise S.B. Effect of orange juice on the bioavailability of carbamazepine. J. Pharm. Res. 2009;2:120\u2013123."}, {"Citation": "Bedada S.K., Nearati P. Effect of resveratrol on the pharmacokinetics of carbamazepine in healthy human volunteers. Phytother. Res. 2015;29:701\u2013706. doi: 10.1002/ptr.5302.", "ArticleIdList": ["10.1002/ptr.5302", "25624269"]}, {"Citation": "Bedada S.K., Boga P.K. Influence of diosmin on the metabolism and disposition of carbamazepine in healthy subjects. Xenobiotica. 2017;47:879\u2013884. doi: 10.1080/00498254.2016.1244368.", "ArticleIdList": ["10.1080/00498254.2016.1244368", "27690733"]}, {"Citation": "Pattanaik S., Hota D., Prabhakar S., Kharbanda P., Pandhi P. Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients. Phytother. Res. 2009;23:1281\u20131286. doi: 10.1002/ptr.2676.", "ArticleIdList": ["10.1002/ptr.2676", "19283724"]}, {"Citation": "Pattanaik S., Hota D., Prabhakar S., Kharbanda P., Pandhi P. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy. Phytother. Res. 2006;20:683\u2013686.", "ArticleIdList": ["16767797"]}, {"Citation": "Nicolussi S., Drewe J., Butterweck V., Meyer Zu Schwabedissen H.E. Clinical relevance of St. John\u2019s wort drug interactions revisited. Br. J. Pharmacol. 2020;177:1212\u20131226. doi: 10.1111/bph.14936.", "ArticleIdList": ["10.1111/bph.14936", "PMC7056460", "31742659"]}, {"Citation": "Gaid M., Biedermann E., F\u00fcller J., Haas P., Behrends S., Krull R., Scholl S., Wittstock U., M\u00fcller-Goymann C., Beerhues L. Biotechnological production of hyperforin for pharmaceutical formulation. Eur. J. Pharm. Biopharm. 2018;126:10\u201326. doi: 10.1016/j.ejpb.2017.03.024.", "ArticleIdList": ["10.1016/j.ejpb.2017.03.024", "28377273"]}, {"Citation": "Novelli M., Masiello P., Beffy P., Menegazzi M. Protective role of St. John\u2019s wort and its components hyperforin and hypericin against diabetes through inhibition of inflammatory signaling: Evidence from in vitro and in vivo studies. Int. J. Mol. Sci. 2020;21:8108. doi: 10.3390/ijms21218108.", "ArticleIdList": ["10.3390/ijms21218108", "PMC7662691", "33143088"]}, {"Citation": "Johne A., Schmider J., Brockm\u00f6ller J., Stadelmann A.M., St\u00f6rmer E., Bauer S., Scholler G., Langheinrich M., Roots I. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John\u2019s wort (Hypericum perforatum) J. Clin. Psychopharmacol. 2002;22:46\u201354. doi: 10.1097/00004714-200202000-00008.", "ArticleIdList": ["10.1097/00004714-200202000-00008", "11799342"]}, {"Citation": "Goey A.K., Meijerman I., Rosing H., Marchetti S., Mergui-Roelvink M., Keessen M., Burgers J.A., Beijnen J.H., Schellens J.H. The effect of St John\u2019s wort on the pharmacokinetics of docetaxel. Clin. Pharmacokinet. 2014;53:103\u2013110. doi: 10.1007/s40262-013-0102-5.", "ArticleIdList": ["10.1007/s40262-013-0102-5", "24068654"]}, {"Citation": "Ra\u017en\u00e1 K., Sawinska Z., Ivani\u0161ov\u00e1 E., Vukovic N., Terentjeva M., Stri\u010d\u00edk M., Kowalczewski P.\u0141., Hlava\u010dkov\u00e1 L., Rovn\u00e1 K., \u017diarovsk\u00e1 J., et al. Properties of Ginkgo biloba L.: Antioxidant characterization, antimicrobial activities, and genomic microRNA based marker fingerprints. Int. J. Mol. Sci. 2020;21:3087. doi: 10.3390/ijms21093087.", "ArticleIdList": ["10.3390/ijms21093087", "PMC7247675", "32349345"]}, {"Citation": "Yoshitake T., Yoshitake S., Kehr J. The Ginkgo biloba extract EGb 761\u00ae and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex. Br. J. Pharmacol. 2010;159:659\u2013668. doi: 10.1111/j.1476-5381.2009.00580.x.", "ArticleIdList": ["10.1111/j.1476-5381.2009.00580.x", "PMC2828029", "20105177"]}, {"Citation": "Uchida S., Yamada H., Li X.D., Maruyama S., Ohmori Y., Oki T., Watanabe H., Umegaki K., Ohashi K., Yamada S. Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers. J. Clin. Pharmacol. 2006;46:1290\u20131298. doi: 10.1177/0091270006292628.", "ArticleIdList": ["10.1177/0091270006292628", "17050793"]}, {"Citation": "Markowitz J.S., Devane C.L., Chavin K.D., Taylor R.M., Ruan Y., Donovan J.L. Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers. Clin. Pharmacol. Ther. 2003;74:170\u2013177. doi: 10.1016/S0009-9236(03)00148-6.", "ArticleIdList": ["10.1016/S0009-9236(03)00148-6", "12891227"]}, {"Citation": "Wang Y., Wang Y., Sui Y., Yu H., Shen X., Chen S., Pei G., Zhao J., Ding J. The combination of aricept with a traditional Chinese medicine formula, smart soup, may be a novel way to treat Alzheimer\u2019s disease. J. Alzheimers Dis. 2015;45:1185\u20131195.", "ArticleIdList": ["25690664"]}, {"Citation": "Watari H., Shimada Y., Matsui M., Tohda C. Kihito, a traditional Japanese kampo medicine, improves cognitive function in Alzheimer\u2019s disease patients. Evid. Based Complement. Altern. Med. 2019;2019:4086749. doi: 10.1155/2019/4086749.", "ArticleIdList": ["10.1155/2019/4086749", "PMC6537006", "31217803"]}, {"Citation": "Chi Y.C., Lin S.P., Hou Y.C. A new herb-drug interaction of Polygonum cuspidatum, a resveratrol-rich nutraceutical, with carbamazepine in rats. Toxicol. Appl. Pharmacol. 2012;263:315\u2013322. doi: 10.1016/j.taap.2012.07.003.", "ArticleIdList": ["10.1016/j.taap.2012.07.003", "22813711"]}, {"Citation": "Raish M., Ahmad A., Alkharfy K.M., Jan B.L., Mohsin K., Ahad A., Al-Jenoobi F.I., Al-Mohizea A.M. Effects of Paeonia emodi on hepatic cytochrome P450 (CYP3A2 and CYP2C11) expression and pharmacokinetics of carbamazepine in rats. Biomed. Pharmacother. 2017;90:694\u2013698. doi: 10.1016/j.biopha.2017.04.015.", "ArticleIdList": ["10.1016/j.biopha.2017.04.015", "28419964"]}, {"Citation": "Raish M., Ahmad A., Ansari M.A., Alkharfy K.M., Ahad A., Al-Jenoobi F.I., Al-Mohizea A.M., Khan A., Ali N. Effects of sinapic acid on hepatic cytochrome P450 3A2, 2C11, and intestinal P-glycoprotein on the pharmacokinetics of oral carbamazepine in rats: Potential food/herb-drug interaction. Epilepsy Res. 2019;153:14\u201318. doi: 10.1016/j.eplepsyres.2019.03.012.", "ArticleIdList": ["10.1016/j.eplepsyres.2019.03.012", "30927680"]}, {"Citation": "Alkharfy K.M., Al-Jenoobi F.I., Al-Mohizea A.M., Al-Suwayeh S.A., Khan R.M., Ahmad A. Effects of Lepidium sativum, Nigella sativa and Trigonella foenum-graceum on phenytoin pharmacokinetics in beagle dogs. Phytother. Res. 2013;27:1800\u20131804. doi: 10.1002/ptr.4947.", "ArticleIdList": ["10.1002/ptr.4947", "23401262"]}, {"Citation": "Chandra R.H., Rajkumar M., Veeresham C. Pharmacokinetic interaction of Ginkgo biloba with carbamazepine. Planta Med. 2009;75:454."}, {"Citation": "Kim H.J., Kim P., Shin C.Y. A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system. J. Ginseng Res. 2013;37:8\u201329. doi: 10.5142/jgr.2013.37.8.", "ArticleIdList": ["10.5142/jgr.2013.37.8", "PMC3659622", "23717153"]}, {"Citation": "Hao M., Zhao Y., Chen P., Huang H., Liu H., Jiang H., Zhang R., Wang H. Structure-activity relationship and substrate-dependent phenomena in effects of ginsenosides on activities of drug-metabolizing P450 enzymes. PLoS ONE. 2008;3:e2697. doi: 10.1371/journal.pone.0002697.", "ArticleIdList": ["10.1371/journal.pone.0002697", "PMC2442655", "18628990"]}, {"Citation": "Zhou Y., Meng D., Chen F., Wu Z., Wang B., Wang S., Geng P., Dai D., Zhou Q., Qiu W. Inhibitory effect of imperatorin on the pharmacokinetics of diazepam in vitro and in vivo. Front. Pharmacol. 2020;11:01079. doi: 10.3389/fphar.2020.01079.", "ArticleIdList": ["10.3389/fphar.2020.01079", "PMC7525091", "33041783"]}, {"Citation": "Bedada W., de Andr\u00e9s F., Engidawork E., Pohanka A., Beck O., Bertilsson L., Llerena A., Aklillu E. The psychostimulant Khat (Catha edulis) inhibits CYP2D6 enzyme activity in humans. J. Clin. Psychopharmacol. 2015;35:694\u2013699. doi: 10.1097/JCP.0000000000000413.", "ArticleIdList": ["10.1097/JCP.0000000000000413", "26444948"]}, {"Citation": "Elkady E.F., Fouad M.A., Alshoba N., Mahmoud S.T. Validated LC-MS/MS method for the determination of some prescribed CNS drugs: Application to an in vivo pharmacokinetic study of drug-herb metabolic interaction potential of khat. Microchem. J. 2020;158:105261. doi: 10.1016/j.microc.2020.105261.", "ArticleIdList": ["10.1016/j.microc.2020.105261"]}, {"Citation": "Yang L., Li C.L., Tsai T.H. Preclinical herb-drug pharmacokinetic interaction of Panax ginseng extract and selegiline in freely moving rats. ACS Omega. 2020;5:4682\u20134688. doi: 10.1021/acsomega.0c00123.", "ArticleIdList": ["10.1021/acsomega.0c00123", "PMC7066651", "32175515"]}, {"Citation": "Chro\u015bci\u0144ska-Krawczyk M., Jargie\u0142\u0142o-Baszak M., Wa\u0142ek M., Tylus B., Czuczwar S.J. Caffeine and the anticonvulsant potency of antiepileptic drugs: Experimental and clinical data. Pharmacol. Rep. 2011;63:12\u201318. doi: 10.1016/S1734-1140(11)70394-2.", "ArticleIdList": ["10.1016/S1734-1140(11)70394-2", "21441607"]}, {"Citation": "Pezzani R., Salehi B., Vitalini S., Iriti M., Zu\u00f1iga F.A., Sharifi-Rad J., Martorell M., Martins N. Synergistic effects of plant derivatives and conventional chemotherapeutic agents: An update on the cancer perspective. Medicina. 2019;55:110.", "ArticleIdList": ["PMC6524059", "30999703"]}, {"Citation": "Zanini C., Giribaldi G., Mandili G., Carta F., Crescenzio N., Bisaro B., Doria A., Foglia L., di Montezemolo L.C., Timeus F., et al. Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing\u2019s sarcoma cell lines. J. Neurochem. 2007;103:1344\u20131354. doi: 10.1111/j.1471-4159.2007.04835.x.", "ArticleIdList": ["10.1111/j.1471-4159.2007.04835.x", "17680992"]}, {"Citation": "Jakubowicz-Gil J., Langner E., Wertel I., Piersiak T., Rzeski W. Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line. Chem. Biol. Interact. 2010;188:190\u2013203. doi: 10.1016/j.cbi.2010.07.015.", "ArticleIdList": ["10.1016/j.cbi.2010.07.015", "20654599"]}, {"Citation": "Brenn A., Grube M., Jedlitschky G., Fischer A., Strohmeier B., Eiden M., Keller M., Groschup M.H., Vogelgesang S.S. John\u2019s Wort reduces beta-amyloid accumulation in a double transgenic Alzheimer\u2019s disease mouse model-role of P-glycoprotein. Brain Pathol. 2014;24:18\u201324.", "ArticleIdList": ["23701205"]}, {"Citation": "Mrozikiewicz P.M., Bogacz A., Bartkowiak-Wieczorek J., Kujawski R., Mikolajczak P.L., Ozarowski M., Czerny B., Mrozikiewicz-Rakowska B., Grzeskowiak E. Screening for impact of popular herbs improving mental abilities on the transcriptional level of brain transporters. Acta Pharm. 2014;64:223\u2013232. doi: 10.2478/acph-2014-0020.", "ArticleIdList": ["10.2478/acph-2014-0020", "24914722"]}, {"Citation": "Zahner C., Kruttschnitt E., Uricher J., Lissy M., Hirsch M., Nicolussi S., Kr\u00e4henb\u00fchl S., Drewe J. No clinically relevant interactions of St. John\u2019s wort extract Ze 117 low in hyperforin with cytochrome P450 enzymes and P-glycoprotein. Clin. Pharmacol. Ther. 2019;106:432\u2013440. doi: 10.1002/cpt.1392.", "ArticleIdList": ["10.1002/cpt.1392", "PMC6766782", "30739325"]}, {"Citation": "Zhang R., Jie J., Zhou Y., Cao Z., Li W. Long-term effects of Panax ginseng on disposition of fexofenadine in rats in vivo. Am. J. Chin. Med. 2009;37:657\u2013667. doi: 10.1142/S0192415X09007144.", "ArticleIdList": ["10.1142/S0192415X09007144", "19655405"]}, {"Citation": "Choi M.K., Song I.S. Interactions of ginseng with therapeutic drugs. Arch. Pharm. Res. 2019;42:862\u2013878. doi: 10.1007/s12272-019-01184-3.", "ArticleIdList": ["10.1007/s12272-019-01184-3", "31493264"]}, {"Citation": "Hui A., Zhu S., Yin H., Yang L., Zhang Z., Zhou A., Pan J., Zhang W. Novel ginkgolide B derivative attenuated the function and expression of P-glycoprotein at the blood-brain barrier, presenting brain-targeting ability. RSC Adv. 2016;6:31101\u201331106. doi: 10.1039/C5RA25248B.", "ArticleIdList": ["10.1039/C5RA25248B"]}, {"Citation": "Zhang C., Fan Q., Chen S.L., Ma H. Reversal of P-glycoprotein overexpression by Ginkgo biloba extract in the brain of pentylenetetrazole-kindled and phenytoin-treated mice. Kaohsiung J. Med. Sci. 2015;31:398\u2013404. doi: 10.1016/j.kjms.2015.05.007.", "ArticleIdList": ["10.1016/j.kjms.2015.05.007", "26228278"]}, {"Citation": "Liang W., Xu W., Zhu J., Zhu Y., Gu Q., Li Y., Guo C., Huang Y., Yu J., Wang W., et al. Ginkgo biloba extract improves brain uptake of ginsenosides by increasing blood-brain barrier permeability via activating A1 adenosine receptor signaling pathway. J. Ethnopharmacol. 2020;246:112243. doi: 10.1016/j.jep.2019.112243.", "ArticleIdList": ["10.1016/j.jep.2019.112243", "31541722"]}, {"Citation": "Bukowska M., Bogacz A., Wolek M., Miko\u0142ajczak P.\u0141., Olbromski P., Kami\u0144ski A., Czerny B. Impact of Curcuma longa extract on the expression level of brain transporters in in vivo model. Herba Pol. 2019;65:32\u201339. doi: 10.2478/hepo-2019-0005.", "ArticleIdList": ["10.2478/hepo-2019-0005"]}, {"Citation": "Zhang D.M., Liu H.Y., Xie L., Liu X.D. Effect of baicalin and berberine on transport of nimodipine on primary-cultured, rat brain microvascular endothelial cells. Acta Pharmacol. Sin. 2007;28:573\u2013578. doi: 10.1111/j.1745-7254.2007.00521.x.", "ArticleIdList": ["10.1111/j.1745-7254.2007.00521.x", "17376298"]}, {"Citation": "Li Y., Paxton J.W. The effects of flavonoids on the ABC transporters: Consequences for the pharmacokinetics of substrate drugs. Expert Opin. Drug Metab. Toxicol. 2013;9:267\u2013285. doi: 10.1517/17425255.2013.749858.", "ArticleIdList": ["10.1517/17425255.2013.749858", "23289831"]}, {"Citation": "Mitsunaga Y., Takanaga H., Matsuo H., Naito M., Tsuruo T., Ohtani H., Sawada Y. Effect of bioflavonoids on vincristine transport across blood-brain barrier. Eur. J. Pharmacol. 2000;395:193\u2013201. doi: 10.1016/S0014-2999(00)00180-1.", "ArticleIdList": ["10.1016/S0014-2999(00)00180-1", "10812049"]}, {"Citation": "Liang G., Li N., Ma L., Qian Z., Sun Y., Shi L., Zhao L. Effect of quercetin on the transport of ritonavir to the central nervous system in vitro and in vivo. Acta. Pharm. 2016;66:97\u2013107. doi: 10.1515/acph-2016-0009.", "ArticleIdList": ["10.1515/acph-2016-0009", "26959546"]}, {"Citation": "Reddy D.R., Khurana A., Bale S., Ravirala R., Reddy V.S.S., Mohankumar M., Godugu C. Natural flavonoids silymarin and quercetin improve the brain distribution of co-administrated P-gp substrate drugs. Springerplus. 2016;5:1618. doi: 10.1186/s40064-016-3267-1.", "ArticleIdList": ["10.1186/s40064-016-3267-1", "PMC5028351", "27652191"]}, {"Citation": "He L., Zhao C., Yan M., Zhang L.Y., Xia Y.Z. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier. Phytother. Res. 2009;23:933\u2013937. doi: 10.1002/ptr.2781.", "ArticleIdList": ["10.1002/ptr.2781", "19172664"]}, {"Citation": "Mahringer A., Karamustafa S., Klotz D., Kahl S., Konkimalla V.B., Wang Y., Wang J., Liu H.Y., Boechzelt H., Hao X., et al. Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine. Cancer Genom. Proteom. 2010;7:191\u2013205.", "ArticleIdList": ["20656985"]}, {"Citation": "Guimar\u00e3es L.P.T.P., Rocha G.G., Queiroz R.M., Martins C.A., Takiya C.M., Gattass C.R. Pomolic acid induces apoptosis and inhibits multidrug resistance protein MRP1 and migration in glioblastoma cells. Oncol. Rep. 2017;38:2525\u20132534. doi: 10.3892/or.2017.5895.", "ArticleIdList": ["10.3892/or.2017.5895", "28849227"]}, {"Citation": "Saeed M.E.M., Mahmoud N., Sugimoto Y., Efferth T., Abdel-Aziz H. Betulinic acid exerts cytotoxic activity against multidrug-resistant tumor cells via targeting autocrine motility factor receptor (AMFR) Front. Pharmacol. 2018;9:481. doi: 10.3389/fphar.2018.00481.", "ArticleIdList": ["10.3389/fphar.2018.00481", "PMC5962668", "29867487"]}, {"Citation": "Gupta Y.K., Gupta M., Chaudhary G., Kohli K. Modulation of antiepileptic effect of phenytoin and carbamazepine by melatonin in mice. Methods Find. Exp. Clin. Pharmacol. 2004;26:99\u2013102. doi: 10.1358/mf.2004.26.2.800061.", "ArticleIdList": ["10.1358/mf.2004.26.2.800061", "15071607"]}, {"Citation": "Forcelli P.A., Soper C., Duckles A., Gale K., Kondratyev A. Melatonin potentiates the anticonvulsant action of phenobarbital in neonatal rats. Epilepsy Res. 2013;107:217\u2013223. doi: 10.1016/j.eplepsyres.2013.09.013.", "ArticleIdList": ["10.1016/j.eplepsyres.2013.09.013", "PMC3870145", "24206906"]}, {"Citation": "Reeta K.H., Mehla J., Pahuja M., Gupta Y.K. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats. Pharmacol. Biochem. Behav. 2011;99:399\u2013407. doi: 10.1016/j.pbb.2011.05.011.", "ArticleIdList": ["10.1016/j.pbb.2011.05.011", "21641922"]}, {"Citation": "Gavzan H., Sayyah M., Sardari S., Babapour V. Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure models. Naunyn Schmiedebergs Arch. Pharmacol. 2015;388:1029\u20131038. doi: 10.1007/s00210-015-1135-0.", "ArticleIdList": ["10.1007/s00210-015-1135-0", "26018398"]}, {"Citation": "Salaroglio I.C., Gazzano E., Kopecka J., Chegaev K., Costamagna C., Fruttero R., Guglielmo S., Riganti C. New tetrahydroisoquinoline derivatives overcome Pgp activity in brain-blood barrier and glioblastoma multiforme in vitro. Molecules. 2018;23:1401. doi: 10.3390/molecules23061401.", "ArticleIdList": ["10.3390/molecules23061401", "PMC6099747", "29890725"]}, {"Citation": "Rejinold N.S., Yoo J., Jon S., Kim Y.C. Curcumin as a novel nanocarrier system for doxorubicin delivery to MDR cancer cells: In vitro and in vivo evaluation. ACS Appl. Mater. Interfaces. 2018;10:28458\u201328470. doi: 10.1021/acsami.8b10426.", "ArticleIdList": ["10.1021/acsami.8b10426", "30064206"]}, {"Citation": "Wang L., Li Z., Zhang X., Wang S., Zhu C., Miao J., Chen L., Cui L., Qiao H. Protective effect of shikonin in experimental ischemic stroke: Attenuated TLR4, p-p38MAPK, NF-\u03baB, TNF-\u03b1 and MMP-9 expression, up-regulated claudin-5 expression, ameliorated BBB permeability. Neurochem. Res. 2014;39:97\u2013106. doi: 10.1007/s11064-013-1194-x.", "ArticleIdList": ["10.1007/s11064-013-1194-x", "24248858"]}, {"Citation": "Deng G., Ma C., Zhao H., Zhang S., Liu J., Liu F., Chen Z., Chen A.T., Yang X., Avery J., et al. Anti-edema and antioxidant combination therapy for ischemic stroke via glyburide-loaded betulinic acid nanoparticles. Theranostics. 2019;9:6991\u20137002.", "ArticleIdList": ["PMC6815966", "31660082"]}, {"Citation": "Zhang Q.L., Fu B.M., Zhang Z.J. Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability. Drug Deliv. 2017;24:1037\u20131044. doi: 10.1080/10717544.2017.1346002.", "ArticleIdList": ["10.1080/10717544.2017.1346002", "28687052"]}, {"Citation": "Tang S., Wang A., Yan X., Chu L., Yang X., Song Y., Sun K., Yu X., Liu R., Wu Z., et al. Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson\u2019s disease. Drug Deliv. 2019;26:700\u2013707. doi: 10.1080/10717544.2019.1636420.", "ArticleIdList": ["10.1080/10717544.2019.1636420", "PMC7577045", "31290705"]}, {"Citation": "Zhou J., Wu X., Zhao Z., Wang Z., Li S., Chen C., Yu S., Qu X., Li K., Tian Y., et al. Preparation of a novel ginkgolide B niosomal composite drug. Open Chem. 2020;18:1064\u20131074. doi: 10.1515/chem-2020-0089.", "ArticleIdList": ["10.1515/chem-2020-0089"]}, {"Citation": "Brantley S.J., Argikar A.A., Lin Y.S., Nagar S., Paine M.F. Herb-drug interactions: Challenges and opportunities for improved predictions. Drug Metab. Dispos. 2014;42:301\u2013317.", "ArticleIdList": ["PMC3935140", "24335390"]}, {"Citation": "Han H.K. Role of transporters in drug interactions. Arch. Pharm. Res. 2011;34:1865\u20131877. doi: 10.1007/s12272-011-1107-y.", "ArticleIdList": ["10.1007/s12272-011-1107-y", "22139686"]}, {"Citation": "Lee S.C., Arya V., Yang X., Volpe D.A., Zhang L. Evaluation of transporters in drug development: Current status and contemporary issues. Adv. Drug Deliv. Rev. 2017;116:100\u2013118. doi: 10.1016/j.addr.2017.07.020.", "ArticleIdList": ["10.1016/j.addr.2017.07.020", "28760687"]}, {"Citation": "Matsuda A., Karch R., Bauer M., Traxl A., Zeitlinger M., Langer O. A prediction method for P-glycoprotein-mediated drug-drug interactions at the human blood-brain barrier from blood concentration-time profiles, validated with PET data. J. Pharm. Sci. 2017;106:2780\u20132786. doi: 10.1016/j.xphs.2017.03.024.", "ArticleIdList": ["10.1016/j.xphs.2017.03.024", "28385544"]}, {"Citation": "Kang S.G., Cho S.E. Neuroimaging biomarkers for predicting treatment response and recurrence of major depressive disorder. Int. J. Mol. Sci. 2020;21:2148. doi: 10.3390/ijms21062148.", "ArticleIdList": ["10.3390/ijms21062148", "PMC7139562", "32245086"]}, {"Citation": "Ryu J.Y., Kim H.U., Lee S.Y. Deep learning improves prediction of drug-drug and drug-food interactions. Proc. Natl. Acad. Sci. USA. 2018;115:4304\u20134311. doi: 10.1073/pnas.1803294115.", "ArticleIdList": ["10.1073/pnas.1803294115", "PMC5939113", "29666228"]}, {"Citation": "Rohani N., Eslahchi C. Drug-drug interaction predicting by neural network using integrated similarity. Sci. Rep. 2019;9:13645. doi: 10.1038/s41598-019-50121-3.", "ArticleIdList": ["10.1038/s41598-019-50121-3", "PMC6754439", "31541145"]}, {"Citation": "Lee G., Park C., Ahn J. Novel deep learning model for more accurate prediction of drug-drug interaction effects. BMC Bioinform. 2019;20:415. doi: 10.1186/s12859-019-3013-0.", "ArticleIdList": ["10.1186/s12859-019-3013-0", "PMC6685287", "31387547"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "16"}, {"Year": "2021", "Month": "1", "Day": "29"}, {"Year": "2021", "Month": "2", "Day": "9"}, {"Year": "2021", "Month": "3", "Day": "6", "Hour": "1", "Minute": "7"}, {"Year": "2021", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["33670407", "PMC7917745", "10.3390/ijms22041809", "ijms22041809"]}}], "PubmedBookArticle": []}